Free Case Evaluation
Connect
With Us

Atrium Medical C-Qur Hernia Mesh Lawsuits Moving Forward

atrium buildingMesh Medical Device News Desk, July 10, 2016 ~ This article is Sponsored Content written by Brett Vaughn, RN, BSN, and JD of the Hollis Law firm, of Overland Park, Kansas, about Atrium Medical Hernia Mesh and specifically its C-Qur hernia mesh.  

As many of you readers know, unlike transvaginal mesh, there are few law firms in the US that are willing to take on hernia mesh cases and with one million hernia surgeries a year, there are many patients experiencing complications who are looking answers.  

If you have hernia mesh and are experiencing complications, please obtain your medical records so you can manage your health care and complications.  

 

by Brett Vaughn, ~ Mesh Medical Device News Desk reports among all of the different mesh manufacturers,  there is a growing number of lawsuits filed against Atrium Medical Corporation. The lawsuits allege severe personal injuries resulting from the failure of the Atrium C-Qur hernia mesh.

Lawsuits against Atrium and their C-Qur hernia mesh are currently pending in federal courts in Texas, Florida and New Hampshire, with more lawsuits likely to be filed in the near future.

Atrium C-Qur mesh from website

Atrium C-Qur mesh from website

 

C-Qur shapes

C-Qur shapes

These suits open another chapter for Atrium Medical, operating out of Hudson, New Hampshire, with its parent company, Maquet, based in Germany.

What’s emerging is a long, tangled story of legal and regulatory problems surrounding the C-Qur line of hernia mesh products.

The C-Qur hernia mesh gained FDA approval through the FDA 510(k) program in 2006, which allowed Atrium to skip thorough pre-market studies. In order to gain 510(k) approval, Atrium had to prove that its mesh was substantially similar to a previously approved mesh.

Just like most transvaginal meshes, Atrium’s C-Qur hernia mesh is made from polypropylene, the polymer plastic that’s known to shrink, cause a foreign body reaction, become infected and erode.

Atrium’s hernia mesh began being implanted at a much higher rate nationwide after Atrium signed a three-year national contract with Premier Inc. in 2010.  Premier is a group purchasing organization (GPO), which supplies over one-thousand hospitals. GPOs are the only type of company in which kickbacks are actually legal.

Legislation was passed a few decades ago with the intent of allowing smaller hospitals to join together in order to increase their purchasing power, thus driving down prices (similar to how insurance works). It has evolved into companies like Premier.

The agreement was for Atrium to provide its hernia mesh in bulk at cheap prices. Premier would then supply its member hospitals with Atrium’s hernia mesh. The member hospitals would typically have to agree to only use Atrium’s hernia mesh. After Atrium was one year into its contract with Premier, Maquet Cardiovascular bought Atrium for over one-half billion dollars.

C-Qur hernia mesh

C-Qur hernia mesh

Shortly after Atrium was acquired by Maquet, the FDA issued a warning letter to Atrium Medical in 2012. The warning letter noted that the manufacturing and sterilization process for the C-Qur hernia mesh was altered without proper test being conducted. The FDA also cited multiple instances of C-Qur hernia mesh infections that the company failed to investigate and report.

The most disturbing revelation was that the FDA found numerous instances of human hair being embedded into Atrium’s sterile medical devices.

In 2013, Atrium issued a class II recall on the C-Qur mesh. Even though there was a recall, none of Atrium’s hernia mesh products were actually pulled from the market. Atrium simply wrote a letter notifying doctors to be aware that the mesh’s coating could stick to the packaging and peel off the mesh itself. The purpose of the the coating is to prevent the polypropylene portion of the mesh from coming into direct contact with a patient’s organs.

Unfortunately, physicians have reported to the FDA experiences of the coating peeling off upon implantation or within days after implantation

Several studies have investigated the complications associated with Atrium’s C-Qur hernia mesh. A study conducted in Belgium had to be stopped early because of an unacceptably high rate of C-Qur hernia mesh infections.

A separate study also experienced infections in nearly every C-Qur hernia mesh that was implanted.

C. Brett Vaughn, Hollis Law

C. Brett Vaughn, Hollis Law

Recently, the FDA sued Atrium and Maquet for introducing adulterated medical devices into interstate commerce.

The FDA was granted a permanent injunction against the facility that manufacturers the C-Qur hernia mesh. Atrium’s hernia mesh was not pulled off the market though.

Many providers have discontinued using the C-Qur hernia mesh; however, it is still being implanted at some hospitals.

Injuries related to Atrium’s hernia mesh can take years to manifest. These injuries include infection, bowel perforation, bowel resection, additional surgeries, severe pain, rejection of the mesh and abdominal rashes. 

Mesh Medical Device News Desk will continue to follow this story and provide updates as this litigation progresses. There is also additional information about the Atrium C-Qur hernia mesh available at the Hollis Law Firm. #

 

5 Comments

  1. Raymond Gore says:

    Hernia mesh

  2. Jennifer Dowell says:

    It states Atrium sent letters to hospital and doctors? Well I checked with my hospital and they never received a letter of recall and she went back to 2008, the head of nursing there said she was going to talk to the doctor that did my surgery and ask him about this, because they have a lot of Atriums products…hmmm, so how many more have been implanted? This crap isn’t right!

    • James Carlton says:

      The article is not entirely correct, there was never a recall letter needed. What was sent was a ‘field safety notice’, which is something different; every hospital received it as and they had to confirm it back to the company.
      This was the letter that was sent:
      https://www.swissmedic.ch/recalllists_dl/08335/Vk_20130904_20-e1.pdf

      • jen says:

        So every hospital they sold to would have a field safety document on file at these hospitals correct? What about the doctors would they have one also? I will be checking on this

      • James, a recall letter was needed. Your are correct that a “field safety notice” was allegedly sent to every facility. I’m not sure where you got the information that every hospital received it, but you are in error. Manufacturing processes were then changed and the C-Qur Edge was discontinued. This constitutes a recall per FDA standards and the public is to be notified.

Post a Comment

Your email is never published nor shared. Required fields are marked *

*
*

© 2016 - 2017 Mesh Newsdesk. All rights reserved.
This news website is designed by NextClient.com.